These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 12767177)
1. Examination of novel zinc-binding groups for use in matrix metalloproteinase inhibitors. Puerta DT; Cohen SM Inorg Chem; 2003 Jun; 42(11):3423-30. PubMed ID: 12767177 [TBL] [Abstract][Full Text] [Related]
2. Using model complexes to augment and advance metalloproteinase inhibitor design. Jacobsen FE; Cohen SM Inorg Chem; 2004 May; 43(10):3038-47. PubMed ID: 15132609 [TBL] [Abstract][Full Text] [Related]
3. Elucidating drug-metalloprotein interactions with tris(pyrazolyl)borate model complexes. Puerta DT; Cohen SM Inorg Chem; 2002 Oct; 41(20):5075-82. PubMed ID: 12354040 [TBL] [Abstract][Full Text] [Related]
4. Model complexes of cobalt-substituted matrix metalloproteinases: tools for inhibitor design. Jacobsen FE; Breece RM; Myers WK; Tierney DL; Cohen SM Inorg Chem; 2006 Sep; 45(18):7306-15. PubMed ID: 16933932 [TBL] [Abstract][Full Text] [Related]
5. New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups. Puerta DT; Lewis JA; Cohen SM J Am Chem Soc; 2004 Jul; 126(27):8388-9. PubMed ID: 15237990 [TBL] [Abstract][Full Text] [Related]
6. Structural and spectroscopic study of reactions between chelating zinc-binding groups and mimics of the matrix metalloproteinase and disintegrin metalloprotease catalytic sites: the coordination chemistry of metalloprotease inhibition. He H; Puerta DT; Cohen SM; Rodgers KR Inorg Chem; 2005 Oct; 44(21):7431-42. PubMed ID: 16212369 [TBL] [Abstract][Full Text] [Related]
7. Docking studies of matrix metalloproteinase inhibitors: zinc parameter optimization to improve the binding free energy prediction. Hu X; Shelver WH J Mol Graph Model; 2003 Nov; 22(2):115-26. PubMed ID: 12932782 [TBL] [Abstract][Full Text] [Related]
8. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor. Nar H; Werle K; Bauer MM; Dollinger H; Jung B J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929 [TBL] [Abstract][Full Text] [Related]
9. Protonation and reactivity towards carbon dioxide of the mononuclear tetrahedral zinc and cobalt hydroxide complexes, [Tp(Bu)t(,Me)]ZnOH and [Tp(Bu)t(,Me)]CoOH: comparison of the reactivity of the metal hydroxide function in synthetic analogues of carbonic anhydrase. Bergquist C; Fillebeen T; Morlok MM; Parkin G J Am Chem Soc; 2003 May; 125(20):6189-99. PubMed ID: 12785851 [TBL] [Abstract][Full Text] [Related]
10. Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs). Zhang YM; Fan X; Yang SM; Scannevin RH; Burke SL; Rhodes KJ; Jackson PF Bioorg Med Chem Lett; 2008 Jan; 18(1):405-8. PubMed ID: 17980583 [TBL] [Abstract][Full Text] [Related]
11. Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors. Dublanchet AC; Ducrot P; Andrianjara C; O'Gara M; Morales R; Compère D; Denis A; Blais S; Cluzeau P; Courté K; Hamon J; Moreau F; Prunet ML; Tertre A Bioorg Med Chem Lett; 2005 Aug; 15(16):3787-90. PubMed ID: 16002291 [TBL] [Abstract][Full Text] [Related]
12. Characterization of alpha-nitromethyl ketone as a new zinc-binding group based on structural analysis of its complex with carboxypeptidase A. Wang SF; Tian GR; Zhang WZ; Jin JY Bioorg Med Chem Lett; 2009 Sep; 19(17):5009-11. PubMed ID: 19646864 [TBL] [Abstract][Full Text] [Related]
13. Structural and functional models of the active site of zinc phosphotriesterase. Carlsson H; Haukka M; Nordlander E Inorg Chem; 2004 Sep; 43(18):5681-7. PubMed ID: 15332820 [TBL] [Abstract][Full Text] [Related]
14. 1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke. Zhang YM; Fan X; Chakaravarty D; Xiang B; Scannevin RH; Huang Z; Ma J; Burke SL; Karnachi P; Rhodes KJ; Jackson PF Bioorg Med Chem Lett; 2008 Jan; 18(1):409-13. PubMed ID: 17981034 [TBL] [Abstract][Full Text] [Related]
15. Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides. Tuccinardi T; Martinelli A; Nuti E; Carelli P; Balzano F; Uccello-Barretta G; Murphy G; Rossello A Bioorg Med Chem; 2006 Jun; 14(12):4260-76. PubMed ID: 16483784 [TBL] [Abstract][Full Text] [Related]
16. Selective recognition of configurational substates of zinc cyclam by carboxylates: implications for the design and mechanism of action of anti-HIV agents. Liang X; Weishäupl M; Parkinson JA; Parsons S; McGregor PA; Sadler PJ Chemistry; 2003 Oct; 9(19):4709-17. PubMed ID: 14566877 [TBL] [Abstract][Full Text] [Related]
17. Solid-state and solution-state coordination chemistry of the zinc triad with the mixed N,S donor ligand bis(2-methylpyridyl) sulfide. Berry SM; Bebout DC; Butcher RJ Inorg Chem; 2005 Jan; 44(1):27-39. PubMed ID: 15627357 [TBL] [Abstract][Full Text] [Related]
18. A new role for old ligands: discerning chelators for zinc metalloproteinases. Jacobsen FE; Lewis JA; Cohen SM J Am Chem Soc; 2006 Mar; 128(10):3156-7. PubMed ID: 16522091 [TBL] [Abstract][Full Text] [Related]
19. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure. Lang R; Kocourek A; Braun M; Tschesche H; Huber R; Bode W; Maskos K J Mol Biol; 2001 Sep; 312(4):731-42. PubMed ID: 11575928 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, structure and spectroscopy of new thiopyrone and hydroxypyridinethione transition-metal complexes. Lewis JA; Tran BL; Puerta DT; Rumberger EM; Hendrickson DN; Cohen SM Dalton Trans; 2005 Aug; (15):2588-96. PubMed ID: 16025179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]